Mission Bio’s Tapestri Platform Used to Distinguish Acute Myeloid Leukemia Clones from CHIP Clones

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., May 25, 2021 /PRNewswire/ -- Mission Bio, the life sciences company delivering single-cell resolution multi-omics tools to accelerate discoveries and improve time-to-market for new therapeutics, announced today a new peer-reviewed study published using the Tapestri Platform's single-cell multi-omics solution to accurately distinguish...

Click to view original post